Skip to content
Hemispherx Biopharma, Inc. Logo
  • COMPANY
  • PRODUCTS
  • R & D
    • Product Candidates Overview
    • Pipeline
    • Orphan Drug Designations
  • PARTNERING
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • XBRL Filings
    • Stockholder Meeting
    • Corporate Governance
    • Email Alerts
    • Investor Contact
  • BLOG
  • CONTACT

Press Releases

 
Apr 08, 2002
Hemispherx Announces Fourth Quarter and Full Year Results

Apr 02, 2002
Hemispherx to Present Today At 1:30 PM On the American Stock Exchange Invitation On Line Conference

Mar 26, 2002
Hemispherx Biopharma Launches New Website

Mar 19, 2002
Hemispherx Disseminates New Clinical Data on Experimental Treatment of Multi-Drug Resistant HIV/AIDS Virus Virus Levels Observed to Drop

Mar 18, 2002
Hemispherx Announces Poly I:Poly C12U Increases the Control of HIV During Strategic Treatment Interruption in Chronically HIV Infected Patients

Feb 27, 2002
Hemispherx to Present New Clinical Data on Experimental Treatment of Multi-Resistant HIV/AIDS Virus

Feb 22, 2002
Hemispherx Defamation Trial Results in Claims of Both Parties Being Denied Jury Fails To Award Damages Against Asensio;

Jan 28, 2002
Hemispherx Continues To Enroll New Clinical Investigators And Expand Clinical Trial Sites In HIV Trials Company Also Prepares To Present At Upcoming Scientific Conferences

Dec 04, 2001
Hemispherx Comments on New Report From U.S. Agency for Healthcare Research and Quality -- AHRQ -- on Chronic Fatique Syndrome -- CFS --

Nov 14, 2001
HEMISPHERx ANNOUNCES THIRD QUARTER FINANCIAL RESULTS

 70   71   72   73   74     75    76 
 <<   <   >   >> 
Hemispherx Biopharma, Inc. Logo White

Latest News

  • CEO Roadshow Interviews Hemispherx Thomas K. Equels
  • Introducing You to the First Ampligen Quarterly Update
  • Proactive Investors USA Sits Down with Hemispherx CEO Thomas K. Equels

Privacy / Terms of Use

  • Terms Of Use
  • Investor Contact

Tweets by AIM Immuno

© Copyright | All Rights Reserved | AIM ImmunoTech Inc. | Privacy Policy | Terms of Use
FacebookTwitterYouTubeLinkedIn

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window